This presentation provides a brief, clinically focused overview of psychedelics and their emerging relevance to eating disorder treatment. Proposed mechanisms, including effects on cognitive rigidity, self-concept, and emotional processing, will be reviewed alongside a high-level summary of the current evidence. Practical considerations such as safety risks, patient selection, developmental issues, and how to respond to patient inquiries will be emphasized. The goal is to equip clinicians with a balanced, evidence-informed framework for discussing psychedelics in eating disorder care.